Health accessories for iPhones, iPads, and iPods have become more numerous and diverse over the years, evolving from Apple’s early Nike+ run sensors to heart rate monitors, increasingly complex Wi-Fi ...
AliveCor, Inc., the leader in FDA-cleared ECG technology for mobile devices, announced today a strategic partnership with LifeWatch AG (SIX Swiss Exchange: LIFE), a leading developer of medical ...
AliveCor has added blood pressure testing data to its iOS network Kardia app, the companion app for AliveCor’s FDA-cleared smartphone electrocardiogram device. The blood pressure component has been ...
If you've been gazing longingly at the AliveCor Heart Monitor but an Android affinity has kept you out in the cold, its developer has good news. Starting today, AliveCor's clinical-quality (and now ...
SAN FRANCISCO--(BUSINESS WIRE)--AliveCor announced today that its mobile Heart Monitor for iPhone is now available by prescription to enable patients to record their heart rhythm anytime, anywhere.
AliveCor focuses on single- and six-lead smartphone ECGs and artificial intelligence-based reading interpretations. Its latest product, a six-lead ECG device, was launched in June of this year. Dubbed ...
PALO ALTO, Calif.--(BUSINESS WIRE)--Medable, Inc., the leading global platform for decentralized clinical trials, and AliveCor, the leader in AI-based, personal ECG technology, today announced a ...
This morning, San Francisco-based AliveCor rebranded its AliveCor Mobile ECG device as Kardia Mobile and unveiled a second, upcoming hardware product, an Apple Watch strap that can take ...
The Food and Drug Administration has given clearance to AliveCor’s next generation of interpretive ECG algorithms, used in personal cardiology devices to support telemedicine. AliveCor’s KardiaMobile ...
While Watch Series 4 and its successors will undoubtedly bring this life-saving technology to millions of people over the next several years, Apple was not the first to bring it to market. That ...
Mayo Clinic, AliveCor develop mobile EKG device to monitor patients at risk of sudden cardiac death Researchers from Rochester, Minn.-based Mayo Clinic and AliveCor, a cardiology-focused medical ...